Management of type 2 diabetes mellitus and cardiovascular risk: Lessons from intervention trials

Drugs

Volumn 60, Issue 5, 2000, Pages 975-983

  Yki Järvinen, Hannele ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CERIVASTATIN; CHLORPROPAMIDE; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FENOFIBRATE; FOSINOPRIL; GEMFIBROZIL; GLIBENCLAMIDE; GLIPIZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; MEVINOLIN; NISOLDIPINE; NITRENDIPINE; PLACEBO; PRAVASTATIN; RAMIPRIL; SIMVASTATIN;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DYSLIPIDEMIA; EPIDEMIC; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; LIFESTYLE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; REVIEW; RISK FACTOR;

EID: 0033668631     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200060050-00001     Document Type: Review

References (59)

1. Insulin, insulin resistance and platelet function: Similarities with insulin effects on cultured vascular smooth muscle cells
2. Pathogenesis of non-insulin-dependent diabetes mellitus
3. Role of insulin resistance in the pathogenesis of NIDDM
4. Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice
5. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction. Data from the GISSI-3 study
6. Uniformity of captopril benefit in the SAVE study: Subgroup analysis. Survival and Ventricular Enlargement Study
7. Angio-converting enzyme inhibition after myocardial infarction: The Trandolapril Cardiac Evaluation Study
8. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
9. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
10. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
11. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty
12. Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: Evidence for a complex interaction in a multicenter trial. EPILOG investigators
13. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial
14. Hypertension in diabetes study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications
15. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
16. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: The Insulin Resistance Atherosclerosis Study
17. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 years
18. Hyperglycemia and cardiovascular disease in type 2 diabetes
19. Hyperglycemia and microvascular and macrovascular disease in diabetes
20. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
21. PAI-1, obesity, insulin resistance and risk of cardiovascular events
22. Insulin resistance and thrombosis: A cardiologist's view
23. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM
24. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM
25. Albuminuria and poor glycemic control predict mortality in NIDDM
26. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: The Hoorn Study
27. Heterogeneous nature of microalbuminuria in NIDDM: Studies of endothelial function and renal structure
28. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
29. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older patients with isolated systolic hypertension
30. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
31. Principal results of the Captopril Prevention Project (CAPPP): Effect of angiotensin converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension
32. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
33. Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial (FACET) in patients with hypertension and NIDDM
34. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the hypertension optimal treatment (HOT) randomized trial
35. Diabetes and arterial hypertension
36. Diabetic nephropathy and arterial hypertension
37. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
38. Vitamin E supplementation and cardiovascular events in high-risk patients
39. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
40. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
41. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels. Subgroup analyses in the cholesterol and recurrent events (CARE) trial
42. Cholesterol lowering with simvastatin imrpoves prognosis of diabetic patients with coronary heart disease: A subgroup analysis of the Scandinavian Survival Study (4S)
43. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
44. Role of fibrates in the management of hypertriglyceridemia
45. Management of dyslipidemia in adults with diabetes
46. A strategy for arterial risk assessment and management in type 2 (non- insulin-dependent) diabetes mellitus
47. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent mellitus: A randomized prospective 6-year study
48. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
49. Effect of intensive blood-glucose control with metformin on complica tions in overweight patients with type 2 diabetes (UKPDS 34)
50. Final report on the aspirin component of the ongoing Physicians' Health Study
51. Aspirin effects on mortality and morbidity in patients with diabetes mellitus
52. Collaborative overview of randomized trails of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
53. Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease
54. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
55. Developing risk stratification charts for diabetic and nondiabetic subjects
56. Prevention of coronary heart disease in clinical practice. European recommendations revised and reinforced
57. UKPDS 28: A randomized trial of efficacy of early addition of metformin in sufonylurea-treated type 2 diabetes
58. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus: A randomized, controlled trial
59. Glycemic control in patients with diabetes in Finland